Theravance Biopharma

$18.93
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$1.23 (-6.13%) As of 10:52 AM EDT today

Why Robinhood?

You can buy or sell TBPH and other stocks, options, and ETFs commission-free!

About TBPH

Theravance Biopharma, Inc. operates as a biopharmaceutical company. It focuses on the discovery, research, development, and commercialization of organ-selective medicines. Read More Its products include telavancin under the VIBATIV brand, revefenacin under the TD 4208 brand, and neprilysin. The company was founded in July 2013 and is headquartered in George Town, Cayman Islands. The listed name for TBPH is Theravance Biopharma, Inc. Ordinary Shares.

Employees
316
Headquarters
George Town, George Town
Founded
2013
Market Cap
1.21B
Price-Earnings Ratio
Dividend Yield
Average Volume
380.45K
High Today
$19.88
Low Today
$18.63
Open Price
$19.78
Volume
76.58K
52 Week High
$31.54
52 Week Low
$14.48

Collections

TBPH Earnings

-$1.32
-$0.55
$0.21
$0.98
Q1 2019
Q2 2019
Q3 2019
Q4 2019
Q1 2020
Q2 2020
Q3 2020
Estimated
per share
Actual
Available Nov 5, After Hours

You May Also Like